Literature DB >> 33562770

Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions.

Kyosuke Suzuki1, Kohsaku Kawakami2, Masafumi Fukiage3, Michinori Oikawa4, Yohei Nishida5, Maki Matsuda6, Takuya Fujita7.   

Abstract

Amorphous solid dispersion (ASD) is one of the most promising formulation technologies for improving the oral absorption of poorly soluble drugs, where the maintenance of supersaturation plays a key role in enhancing the absorption process. However, quantitative prediction of oral absorption from ASDs is still difficult. Supersaturated solutions can cause liquid-liquid phase separation through the spinodal decomposition mechanism, which must be adequately comprehended to understand the oral absorption of drugs quantitatively. In this study, albendazole (ALZ) was formulated into ASDs using three types of polymers, poly(methacrylic acid-co-methyl methacrylate) (Eudragit) L100, Vinylpyrrolidone-vinyl acetate copolymer (PVPVA), and hydroxypropyl methylcellulose acetate succinate (HPMCAS). The oral absorption of ALZ in rats administered as ASD suspensions was not explained by dissolution study but was predicted using liquid-liquid phase separation concentration, which suggested that the absorption of ALZ was solubility-limited. The oral administration study in dogs performed using solid capsules demonstrated the low efficacy of ASDs because the absorption was likely to be limited by dissolution rate, which indicated the importance of designing the final dosage form of the ASDs.

Entities:  

Keywords:  albendazole; amorphous solid dispersions; dissolution study; liquid-liquid phase separation; oral absorption; supersaturation

Year:  2021        PMID: 33562770      PMCID: PMC7914868          DOI: 10.3390/pharmaceutics13020220

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  20 in total

Review 1.  Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.

Authors:  Kohsaku Kawakami
Journal:  Adv Drug Deliv Rev       Date:  2012-01-13       Impact factor: 15.470

2.  Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.

Authors:  Shweta A Raina; Geoff G Z Zhang; David E Alonzo; Jianwei Wu; Donghua Zhu; Nathaniel D Catron; Yi Gao; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-05-28       Impact factor: 4.200

Review 3.  Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.

Authors:  Jan Bevernage; Joachim Brouwers; Marcus E Brewster; Patrick Augustijns
Journal:  Int J Pharm       Date:  2012-11-27       Impact factor: 5.875

Review 4.  Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.

Authors:  Amrit Paudel; Zelalem Ayenew Worku; Joke Meeus; Sandra Guns; Guy Van den Mooter
Journal:  Int J Pharm       Date:  2012-07-20       Impact factor: 5.875

Review 5.  Physical chemistry of supersaturated solutions and implications for oral absorption.

Authors:  Lynne S Taylor; Geoff G Z Zhang
Journal:  Adv Drug Deliv Rev       Date:  2016-03-22       Impact factor: 15.470

Review 6.  Supersaturation and crystallization: non-equilibrium dynamics of amorphous solid dispersions for oral drug delivery.

Authors:  Kohsaku Kawakami
Journal:  Expert Opin Drug Deliv       Date:  2016-09-09       Impact factor: 6.648

7.  Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids.

Authors:  Ahmed Elkhabaz; Dana E Moseson; Joachim Brouwers; Patrick Augustijns; Lynne S Taylor
Journal:  Mol Pharm       Date:  2019-11-14       Impact factor: 4.939

8.  Drug precipitation-permeation interplay: supersaturation in an absorptive environment.

Authors:  Jan Bevernage; Joachim Brouwers; Pieter Annaert; Patrick Augustijns
Journal:  Eur J Pharm Biopharm       Date:  2012-07-25       Impact factor: 5.571

9.  Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.

Authors:  Ryusuke Takano; Reto Maurer; Laurence Jacob; Frank Stowasser; Cordula Stillhart; Susanne Page
Journal:  Mol Pharm       Date:  2020-07-21       Impact factor: 4.939

10.  Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.

Authors:  Justin M Keen; Justin S LaFountaine; Justin R Hughey; Dave A Miller; James W McGinity
Journal:  AAPS PharmSciTech       Date:  2017-11-30       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.